Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLID.L Regulatory News (LID)

  • There is currently no data for LID

Software Link with Picis

25 Apr 2006 07:00

For immediate release 25 April 2006 LiDCO Group plc Software Link with Picis LiDCO Group plc (AIM: LID), the cardiovascular monitoring company, is pleasedto announce that Picis, the leading provider of high-acuity care automationsoftware for hospitals, is to create a custom device link between LiDCO'sproprietary, stand-alone monitoring system and the Picis CareSuite¢â€ž¢ hospitalinformation management system (HIS) or any other HIS that Picis communicatesto. Once completed, the communications link will allow Picis customers accessto LiDCO's proprietary, minimally-invasive hemodynamic monitoring data. Theintegration of critical care parameters and data derived from the LiDCOplusmonitor will allow a full picture of the patient's condition and history to bedisplayed and accessed throughout the hospital.LiDCO's CEO, Dr. Terry O'Brien, commented: "The communications link willfurther enhance the utility of the LiDCOplus system for both our existing andfuture Picis customers. LiDCO will continue to explore additional non-exclusivecollaborations with the major corporations providing monitoring products to theacute care hospital market. Our ambition is to make LiDCO's technology thestandard of care throughout the hospital for minimally-invasive hemodynamicmonitoring."For further information please contact:LiDCO Group Plc Tel: +44 (0)20 7749 1500 Terry O'Brien - Chief Executive Hugh McGarel-Groves - Finance Director Buchanan Communications Tim Anderson, James Strong Tel: +44 (0)20 7466 5000 Panmure Gordon Grant Harrison, Aubrey Powell, Katherine Roe Tel: +44 (0)20 7459 3600 Notes to EditorsAbout LiDCO PlcLiDCO is a UK-based AIM-traded developer, manufacturer and leading supplier ofminimally invasive, computer-based hemodynamic monitoring equipment anddisposables used primarily for the management of critical care andcardiovascular risk hospital patients. Use of LiDCO's technology has been shownto significantly reduce the complications (particularly infections) and costsassociated with major surgery. The technology was invented in the Department ofApplied Physiology based at St Thomas' Hospital, London where the Companymaintains a research base.The Company's manufacturing facility is in Hoxton, London and its currentproducts are: * LiDCOplus and PulseCO monitors: computer-based platforms for displaying a range of real-time, continuous hemodynamic parameters including cardiac output, oxygen delivery and fluid volume; * LiDCO disposables: used in conjunction with the LiDCOplus Monitor to accurately determine cardiac output in a minimally-invasive manner. Distribution Network:The Company has now achieved registration of its products in 16 markets inEurope, the USA, Brazil and Japan. It sells direct to the NHS in the UK, andthrough a worldwide network of specialty critical care distributors.About PicisPicis is the leading, worldwide provider of information systems that deliverproven best-in-cluster patient care transformation for the highest-acuity careareas of the hospital - the emergency department, the operating room and theintensive care unit. Headquartered in Wakefield, Massachusetts, Picis hasinstalled systems in more than 900 medical centers and hospital networksworldwide including over 700 in North America, automating more surgicalprocedures, emergency visits and intensive care stays than any other company inthe world. Picis has received numerous awards, including those from Microsoft,Ernst & Young, HCIT Research, Healthcare Informatics and Frost and Sullivan.Picis was recently named to both the Deloitte & Touche Fast 500 and the Inc.Magazine 500 lists (105th overall) of the fastest growing private companies inthe U.S. More information is available at www.picis.com.ENDLIDCO GROUP PLC
Date   Source Headline
5th Dec 20077:00 amPRNClinical Study Results
16th Nov 20077:00 amPRNPlacing of Shares
30th Oct 20077:00 amPRNInterim Results
29th Aug 20077:00 amPRNTrading Statement
15th Aug 20073:11 pmPRNAIM Rule 26
31st Jul 200712:45 pmPRNDirector/PDMR Shareholding
17th Jul 20077:00 amPRNAnnual Report and Accounts
28th Jun 20079:35 amPRNDirector/PDMR Shareholding
25th Jun 20075:14 pmPRNGrant of Options
22nd Jun 200710:45 amPRNAGM Result
21st Jun 20077:00 amPRNTrading Update & AGM Statement
20th Jun 20077:00 amPRNUS Patent Grant
14th Jun 20078:57 amRNSHolding(s) in Company
7th Jun 20077:00 amPRNBD Collaboration
9th May 20077:00 amPRNApproval of Products in South Korea
24th Apr 20073:10 pmPRNNotice of AGM
19th Apr 20077:00 amPRNPreliminary Results
29th Mar 20077:00 amPRNClinical Study Data
26th Mar 20077:00 amPRNNotice of Results & AGM
21st Mar 20077:00 amPRNRelease of LiDCOlive
20th Mar 20072:28 pmRNSHolding(s) in Company
20th Mar 20071:56 pmRNSHolding(s) in Company
20th Mar 200712:55 pmRNSHolding(s) in Company
19th Mar 20074:33 pmRNSHolding(s) in Company
19th Mar 20073:22 pmPRNDirector/PDMR Shareholding
19th Mar 20073:21 pmPRNDirector/PDMR Shareholding
16th Mar 20074:54 pmRNSHolding(s) in Company
23rd Feb 20077:00 amPRNTrading Update
1st Feb 20074:11 pmPRNVoting Rights & Capital
26th Jan 20074:47 pmPRNAdditional Listing
23rd Jan 20077:00 amPRNPediatric Study
22nd Jan 20075:48 pmPRNDirectorate Change
15th Dec 200610:31 amPRNTotal Voting Rights
28th Nov 20067:00 amPRNTrading Update
18th Oct 20067:00 amPRNInterim Results
9th Oct 20062:00 pmPRNNew Software
3rd Oct 20067:00 amPRNR & D Day
25th Sep 20067:00 amPRNShare Listing
19th Sep 20067:00 amPRNContract Extension
22nd Aug 20067:00 amPRNTrading Update
25th Jul 20065:53 pmPRNDirector/PDMR Shareholding
23rd Jun 20064:51 pmPRNGrant of Options
6th Jun 20067:00 amPRNProduct Registration in Switzerland
23rd May 20064:10 pmPRNResult of EGM
28th Apr 200612:58 pmPRNPlacing
28th Apr 200612:57 pmPRNFinal Results
25th Apr 20066:20 pmPRNChange of results day
25th Apr 20067:00 amPRNSoftware Link with Picis
28th Mar 20067:00 amPRNAward Win
14th Feb 20067:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.